AzTrials
AzTrials

Protein Digestion KineticsPARROTNCT02546141

Postprandial Plasma Amino Acid Concentrations After Dairy Consumption

A study testing skimmed milk (UHT), skimmed milk (pasteurized) and skimmed yoghurt in people with Protein Digestion Kinetics, run by NIZO Food Research at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study was designed to obtain information about the change in postprandial amino acids in blood over time, after consumption of different dairy products, in an elderly population and how this relates to gastric emptying rate and feelings of satiety. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Protein Digestion Kinetics
What is being tested?
skimmed milk (UHT), skimmed milk (pasteurized) and skimmed yoghurt
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteNetherlands
Study dates
Oct 2015to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age over 60y
  • BMI 21-30 kg/m2
  • Non-smoking
  • Healthy as assessed by the NIZO lifestyle and health questionnaire
  • Regular and normal Dutch eating habits as assessed by the NIZO lifestyle and health questionnaire (3 main meals per day)
  • Veins suitable for cannulation (blood sampling)

Who cannot join

  • Participation in any clinical trial including blood sampling and/or administration of substances up to 30 days before Day 01 of this study
  • Having a history of medical or surgical events that may significantly affect the study outcome, including: Inflammatory bowel disease, hepatitis, pancreatitis, ulcers, gastrointestinal or rectal bleeding; major gastrointestinal tract surgery such as gastrectomy, gastroenterostomy, or bowel resection; known or suspected gastrointestinal disorders, colon or GI tract cancer
  • Use of the following medication: glucose lowering drugs, insulin; medication that may impact gastric emptying (e.g. gastric acid inhibitors or laxatives)
  • Diagnosed with diabetes, being treated for high blood glucose or increased fasting blood glucose (> 7 mmol/l in finger prick blood) as assessed during screening visit
  • For men: Hb <8,5 mmol/l as assessed during screening visit; for women: Hb <7,5 mmol/l.
  • Use of protein supplements
Show all 17Show fewer
  • Mental status that is incompatible with the proper conduct of the study
  • A self-reported reported food allergy or sensitivity to dairy ingredients
  • A self-reported allergy or sensitivity to acetaminophen
  • Alcohol consumption > 28 units/week and 4/day
  • Reported unexplained weight loss or weight gain of > 3 kg in the month prior to pre-study screening, or intention to lose weight during the study period
  • Reported slimming or medically prescribed diet
  • Recent blood donation (<1 month prior to Day 01 of the study)
  • Not willing or afraid to give up blood donation during the study
  • Personnel of NIZO food research or Wageningen University, department of Human Nutrition, their partner and their first and second degree relatives
  • Not having a general practitioner
  • Not willing to accept information-transfer concerning participation in the study, or information regarding his health, like laboratory results and eventual adverse events to and from his general practitioner

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • NIZO food research

    Ede

Other trials in Netherlands

About this study

This study was designed to obtain information about the change in postprandial amino acids in blood over time, after consumption of different dairy products, in an elderly population and how this relates to gastric emptying rate and feelings of satiety.

Being tested
skimmed milk (UHT), skimmed milk (pasteurized), skimmed yoghurt, full-fat milk (UHT), non-homogenized full-fat milk (pasteurized)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • skimmed milk (UHT)Other

  • skimmed milk (pasteurized)Other

  • skimmed yoghurtOther

  • full-fat milk (UHT)Other

  • non-homogenized full-fat milk (pasteurized)Other

  • full-fat cheese (semi-matured)Other

  • whey proteinOther

  • micellar caseinOther

Study groups in NCT02546141
Study groupRoleWhat they receive
skimmed milk (UHT)Active comparatorportion size that contains 25 g of protein, oral, single administration
Receives: Other: skimmed milk (UHT)
skimmed milk (pasteurized)Active comparatorportion size that contains 25 g of protein, oral, single administration
Receives: Other: skimmed milk (pasteurized)
skimmed yoghurtActive comparatorportion size that contains 25 g of protein, oral, single administration
Receives: Other: skimmed yoghurt
full-fat milk (UHT)Active comparatorportion size that contains 25 g of protein, oral, single administration
Receives: Other: full-fat milk (UHT)
non-homogenized full-fat milk (pasteurized)Active comparatorportion size that contains 25 g of protein, oral, single administration
Receives: Other: non-homogenized full-fat milk (pasteurized)
full-fat cheese (semi-matured)Active comparatorportion size that contains 25 g of protein, oral, single administration
Receives: Other: full-fat cheese (semi-matured)
whey proteinActive comparatorportion size that contains 25 g of protein, oral, single administration
Receives: Other: whey protein
micellar caseinActive comparatorportion size that contains 25 g of protein, oral, single administration
Receives: Other: micellar casein

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. iAUC for postprandial individual plasma amino acids

    Measured: 0-300 min after consumption

  2. Cmax for postprandial individual plasma amino acids

    Measured: 0-300 min after consumption

  3. Tmax for postprandial individual plasma amino acids

    Measured: 0-300 min after consumption

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2015 (estimated)
  2. Study startOct 2015
  3. Primary completionDec 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02546141
Sponsor's protocol ID
NL53912.081.15
Other IDs
METC nr 15/18
Acronym
PARROT
Status last verified
Jan 2016
First submitted
8 Sep 2015
Last updated
12 Jan 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing skimmed milk (UHT), skimmed milk (pasteurized) and skimmed yoghurt in people with Protein Digestion Kinetics, run by NIZO Food Research at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

iAUC for postprandial individual plasma amino acids (time frame: 0-300 min after consumption). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2016; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in